spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

PCI Builds North American Clinical Sales Team

PCI Pharma Services

Philadelphia, USA – 29 August, 2017




Leading outsourcing services provider PCI Clinical Services has expanded its North American Clinical sales team with the appointment of Nadine DuChateau as Business Development Executive.

Following an extensive career in clinical development services with more than 15 years’ experience in the field, Nadine joins the PCI team to support the development of the company’s client base in the Midwest. Prior to PCI, Nadine spent two years at a leading contract development and manufacturing organization in the pharmaceutical and biotechnology sector.

At PCI, Nadine will be responsible for account management and territory growth for the company’s global clinical packaging and logistics services in the Midwest, maintaining and growing market share with key customers while developing new business and cross-selling PCI’s high potency oral solid manufacturing, commercial packaging and analytical testing services.

Welcoming Nadine to PCI, Tim Roberts, PCI North America Business Development Director, commented: “We are thrilled Nadine will be part of our team. She brings a wealth of experience and has a glowing record of accomplishments that she’s achieved over her career. We are looking forward to working with her here at PCI Clinical Services and her insightful contributions to the success of our clients.”

Nadine said: “I am excited for this new opportunity given PCI’s reputation as the market leader. I’m really looking forward to joining the team and leveraging my experience in my new role to deliver great results for both new and current clients.”

PCI has announced considerable investment in its Clinical Trials business over the past year, including the expansion of its Cold Chain infrastructure at its North American clinical logistics facility in Rockford, IL, expanding onsite cryogenic storage to complement its extensive refrigerated and frozen on-site storage. In addition, the company announced a significant site expansion of its Bridgend, Wales, UK clinical center of excellence, which recently reached practical completion. PCI’s Bridgend site specializes in a broad range of temperature controlled storage and distribution capabilities including cryogenic storage, complementing services at the Rockford site.

These developments follow PCI’s announcement of its site expansion for its drug development and clinical trial manufacturing center of excellence in Tredegar, Wales, UK, including the purchase of a fully contained Xcelodose 600 unit for contained development of potent compounds in early phase clinical study.

To find out more about PCI, please visit www.pciservices.com.

About PCI

The global healthcare industry trusts PCI for the drug development solutions that increase their products’ speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches a year and over four decades in the healthcare business. Leading technology and continued investment enables us to address global development needs throughout the product life cycle — from Phase I clinical trials through commercialization and ongoing supply. Our clients view us as an extension of their business and a collaborative partner, with the shared goal of improving patients’ lives. For more information, please visit www.pciservices.com or follow us on Twitter at @PCI_Social.

Contact


Chantel Richman / Fotini Efstathiou at Remarkable Content
chantel.richman@remarkablegroup.co.uk / Fotini@remarkablegroup.co.uk

T: 0117 247 0158 / 01962 853 929
phone +44 (0)1495 713 633
email sales@pciservices.com
web www.pciservices.com
email Wye Valley Business Park, Hay-on-Wye, HR3 5PG
 
Print this page
Send to a friend
   
spacer
News and Press Releases

TheVax Genetics Vaccine CO., Ltd and Biotechpharma UAB to collaborate on cGMP production of THEVAX HBV Vaccine

VILNIUS, Lithuania and TAIPEI, Taiwan, April 30, 2018 /PRNewswire/ -- TheVax Genetics Vaccine CO., Ltd (6567.TWO) and Biotechpharma UAB have entered into a manufacturing agreement to produce THEVAX HBV vaccine for first-in-human clinical trials.
More info >>


White Papers

Technology Solutions - Driving efficiencies, quality and operational excellence

Worldwide Clinical Trials Ltd

Clinical trials involve the entry, analysis and reporting of millions of pieces of data; year-on-year, the amount of data required to manage efficacy and safety increases exponentially. Recently, solutions available to support this activity have grown in numbers and complexity. The rise of Tablets and Smart Phones combined with the growth of Cloud or SAS solutions has resulted in the technology landscape required to support complex, global studies becoming more confusing.
More info >>

Industry Events

PREP 2018: 31st International Symposium and Exhibit on Preparative and Process Chromatography

8-11 July 2018, Hyatt Regency in the Baltimore Inner Harbor, MD, USA

The PREP series of symposia is the most recognized international conference devoted to advances in separation technologies in the field of preparative and process chromatography. Join us for a dynamic and innovative program where experts from around the world will address the latest developments and hottest topics in preparative and process chromatography.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement